Literature DB >> 16061561

Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.

D G R Evans1, E R Maher, M E Baser.   

Abstract

It has been suggested that somatic mutations that accumulate due to an age related decline in the efficiency of DNA repair mechanisms might contribute to the increased incidence of cancer in older people. However, there is little direct evidence for this phenomenon. The spectra of germline and somatic mutations can be compared in cancer genes that cause inherited tumour syndromes and sporadic tumours, respectively. In addition, mosaic patients reflect the nature of mutations that occur in early development. Hence, we hypothesised that the "temporal mutation record" of a human cancer gene might provide insight into mechanisms of mutagenesis in the germline, in early development, and in adulthood. We compared the ratio of frameshift to nonsense mutations in three diseases that are related to the NF2 tumour suppressor gene: classic neurofibromatosis 2 (NF2), caused by germline NF2 mutations; mosaic NF2; and unilateral sporadic vestibular schwannoma (USVS), caused by somatic NF2 inactivation. Nonsense mutations predominated in both classic and mosaic NF2, but the ratio of nonsense to frameshift mutations was reversed in USVS. Moreover, in USVS patients, the ratio of somatic frameshift to nonsense mutations increased significantly with increasing age at diagnosis. This pattern is consistent with an age related decline in the efficiency of DNA repair mechanisms. Similar studies for other familial cancer genes may provide further evidence for this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061561      PMCID: PMC1736122          DOI: 10.1136/jmg.2004.027953

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  29 in total

1.  Distribution of spontaneous CpG-associated G:C --> A:T mutations in the lacZ gene of Muta mice: effects of CpG methylation, the sequence context of CpG sites, and severity of mutations on the activity of the lacZ gene product.

Authors:  H Ikehata; M Takatsu; Y Saito; T Ono
Journal:  Environ Mol Mutagen       Date:  2000       Impact factor: 3.216

2.  Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.

Authors:  T Kino; H Takeshima; M Nakao; T Nishi; K Yamamoto; T Kimura; Y Saito; M Kochi; J Kuratsu; H Saya; Y Ushio
Journal:  Genes Cells       Date:  2001-05       Impact factor: 1.891

3.  Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents.

Authors:  M T Sgambati; C Stolle; P L Choyke; M M Walther; B Zbar; W M Linehan; G M Glenn
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

4.  Rare HRAS1 alleles are a risk factor for the development of brain tumors.

Authors:  A Vega; M J Sobrido; C Ruiz-Ponte; F Barros; A Carracedo
Journal:  Cancer       Date:  2001-12-01       Impact factor: 6.860

5.  Incidence of vestibular schwannoma in Denmark, 1977-1995.

Authors:  M F Howitz; C Johansen; M Tos; S Charabi; J H Olsen
Journal:  Am J Otol       Date:  2000-09

Review 6.  DNA polymerase-beta may be the main player for defective DNA repair in aging rat neurons.

Authors:  K S Rao; V V Annapurna; N S Raji
Journal:  Ann N Y Acad Sci       Date:  2001-04       Impact factor: 5.691

7.  Through a glass, darkly: reflections of mutation from lacI transgenic mice.

Authors:  G R Stuart; B W Glickman
Journal:  Genetics       Date:  2000-07       Impact factor: 4.562

8.  Age-related hypermethylation of the 5' region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development.

Authors:  H Nakagawa; G J Nuovo; E E Zervos; E W Martin; R Salovaara; L A Aaltonen; A de la Chapelle
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

9.  Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells.

Authors:  M F Chan; R van Amerongen; T Nijjar; E Cuppen; P A Jones; P W Laird
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis.

Authors:  H Lamlum; M Ilyas; A Rowan; S Clark; V Johnson; J Bell; I Frayling; J Efstathiou; K Pack; S Payne; R Roylance; P Gorman; D Sheer; K Neale; R Phillips; I Talbot; W Bodmer; I Tomlinson
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

View more
  8 in total

1.  Origins of biallelic inactivation of NF2 in neurofibromatosis type 2.

Authors:  Lu Xue; Weiwei He; Yi Zhang; Zhigang Wang; Hongsai Chen; Zhe Chen; Weidong Zhu; Dongmei Liu; Huan Jia; Yi Jiang; Zhaoyan Wang; Hao Wu
Journal:  Neuro Oncol       Date:  2022-06-01       Impact factor: 13.029

2.  Age-related dysfunction in mechanotransduction impairs differentiation of human mammary epithelial progenitors.

Authors:  Fanny A Pelissier; James C Garbe; Badriprasad Ananthanarayanan; Masaru Miyano; ChunHan Lin; Tiina Jokela; Sanjay Kumar; Martha R Stampfer; James B Lorens; Mark A LaBarge
Journal:  Cell Rep       Date:  2014-06-05       Impact factor: 9.423

3.  Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005-2015, using the Central Brain Tumor Registry of the United States.

Authors:  Rebecca L Achey; Haley Gittleman; Julia Schroer; Vishesh Khanna; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

4.  Genetic and epigenetic alterations of the NF2 gene in sporadic vestibular schwannomas.

Authors:  Jong Dae Lee; Tae Jun Kwon; Un-Kyung Kim; Won-Sang Lee
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

5.  The molecular biology of vestibular schwannomas and its association with hearing loss: a review.

Authors:  Erika Celis-Aguilar; Luis Lassaletta; Miguel Torres-Martín; F Yuri Rodrigues; Manuel Nistal; Javier S Castresana; Javier Gavilan; Juan A Rey
Journal:  Genet Res Int       Date:  2012-02-20

Review 6.  NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations.

Authors:  Rebecca Dunbar Schroeder; Laura S Angelo; Razelle Kurzrock
Journal:  Oncotarget       Date:  2014-01-15

7.  Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth Patterns.

Authors:  Hongsai Chen; Lu Xue; Hantao Wang; Zhaoyan Wang; Hao Wu
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

Review 8.  Neurofibromatosis type 2 (NF2): a clinical and molecular review.

Authors:  D Gareth R Evans
Journal:  Orphanet J Rare Dis       Date:  2009-06-19       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.